Parkinson's disease overview, treatment options, including deep brain stimulation, and future developments in neurosurgery by ...

Someone will call and say, ‘I was just told I have Parkinson’s disease in a 20-minute visit with my doctor, and I don’t know ...

The pivotal, Phase III study will evaluate the change in average daily “OFF” time in solengepras patients compared to placebo ...

Leading scientists at the National Institutes of Health, the US’s leading medical research agency, were swept up Tuesday in ...

Shaynee ModienLocal Journalism Initiative ReporterThe Shaunavon StandardAround the World, April is Parkinson's Awareness ...

Age-related neurodegenerative disorders — motor neuron diseases, demyelinating diseases, Alzheimer’s disease, and other ...

AC Immune Reports Further Positive Interim Results from Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson's Disease Active immunotherapy with ACI-7104.056 induces high ...

The company is expanding its cardiology portfolio with a new treatment for transthyretin amyloid cardiomyopathy in Europe.

For a decade, she has been unable to do many things as a result of a Parkinson's disease diagnosis. She couldn't cut flowers ...

The new test could help identify which patients are most likely to benefit from new Alzheimer’s drugs. A newly developed ...

This 2025 guide features leading specialists in geriatrics, cardiology, oncology, cosmetic dentistry and cutting-edge ...